13F

Stock

Madrigal Pharmaceuticals, Inc.

MDGL · held by 16 managers

Reported value

$266.8M

Holders

16

+3 new · −0 exited

Holders’ est. mark

$8M

Price effect on 3 books still in the name

Largest holder

$114.5M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY249.6K$114.5M—Held
BANK OF AMERICA CORP /DE/244.3K$112M—Held
BARCLAYS PLC49.9K$22.9M$7.79MAdded$3.92M
GROUPAMA ASSET MANAGMENT27.4K$12.6M—Held
Allworth Financial LP3.55K$1.63M—Held
FARALLON CAPITAL MANAGEMENT LLC3.32K$1.52M—New
Sanctuary Advisors, LLC1.47K$671.9K$198.6KAdded$286.7K
TUDOR INVESTMENT CORP ET AL926$424.7K—Held
Swiss Life Asset Management Ltd646$296.3K—New
IFP Advisors, Inc371$170.2K—Held
Aventura Private Wealth, LLC62$28.4K$9.67KAdded$9.67K
Leonteq Securities AG56$25.7K—New
MV CAPITAL MANAGEMENT, INC.22$10.1K—Held
Cape Investment Advisory, Inc.9$4.13K—Held
KBC Group NV414$190—Held
FNY Investment Advisers, LLC7$3—Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.